Isoniazid-monoresistant tuberculosis in the United States, 1993 to 2003.
about
Rapid Molecular Detection of Multidrug-Resistant Tuberculosis by PCR-Nucleic Acid Lateral Flow ImmunoassayPrevalence, Risk Factors, and Treatment Outcomes of Isoniazid- and Rifampicin-Mono-Resistant Pulmonary Tuberculosis in Lima, PeruThe changing epidemiology of tuberculosis in a Spanish tertiary hospital (1995-2013)Isoniazid resistance and death in patients with tuberculous meningitis: retrospective cohort studyHigh isoniazid resistance rates in rifampicin susceptible Mycobacterium tuberculosis pulmonary isolates from Pakistan.Trends in hospitalizations with antibiotic-resistant infections: U.S., 1997-2006Isoniazid-resistant tuberculous meningitis, United States, 1993-2005.A prospective study of tuberculosis drug susceptibility in sabah, malaysia, and an algorithm for management of isoniazid resistance.Clinical characteristics and treatment outcomes of patients with low- and high-concentration isoniazid-monoresistant tuberculosis.A retrospective analysis of isoniazid-monoresistant tuberculosis: among Iranian pulmonary tuberculosis patients.Isoniazid-resistant tuberculosis in Birmingham, United Kingdom, 1999-2010.Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.Isoniazid-resistant tuberculosis, taiwan, 2000-2010.Treatment duration for patients with drug-resistant tuberculosis, United States.Comparison of isoniazid monoresistant tuberculosis with drug-susceptible tuberculosis and multidrug-resistant tuberculosis.Isoniazid-Monoresistance and Rate of Culture Conversion among Confirmed Tuberculosis Patients in the State of Georgia, 2009 - 2014.
P2860
Q28547835-C8C01A99-C630-423A-951A-D401818A1BF4Q28551162-2F372A51-D94D-4535-B2E9-5BBF9E2BB3D1Q33879669-F5BD1D4B-EDCD-4548-8BA6-55CD8365702EQ34125176-35334484-D7EA-4EC3-B263-9F417FFF3590Q34505509-5C6DE4C9-21D9-4F94-B611-C8534334463AQ34773922-66169AF6-9E05-40D7-B47C-9CD26C098802Q35193575-7A92793A-AD74-4B0D-B189-CE6BA89F73F4Q35206899-69CD4538-54EB-4DC5-BB10-0676CE9C8A28Q37505650-30232909-29AB-4271-8AD7-65BF601BC6A6Q37618035-FDC43580-C343-456B-B617-68C6361E95B8Q38225730-CA22F8D5-AB1A-4801-A0C3-B49955E507C9Q40542672-93F70E44-8CCA-4EF8-813B-ED8E24AB4D7CQ42553039-B426D323-D5EC-43F0-A0A3-F1FFD59D49C2Q43199807-F09112BA-B9B8-4AFD-86A8-2822EA23BBBBQ43544463-08391106-AD9E-4E6F-A528-97DA1A633539Q50048481-67DE986F-A288-4A70-AABA-304FFF034997
P2860
Isoniazid-monoresistant tuberculosis in the United States, 1993 to 2003.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Isoniazid-monoresistant tuberculosis in the United States, 1993 to 2003.
@en
Isoniazid-monoresistant tuberculosis in the United States, 1993 to 2003.
@nl
type
label
Isoniazid-monoresistant tuberculosis in the United States, 1993 to 2003.
@en
Isoniazid-monoresistant tuberculosis in the United States, 1993 to 2003.
@nl
prefLabel
Isoniazid-monoresistant tuberculosis in the United States, 1993 to 2003.
@en
Isoniazid-monoresistant tuberculosis in the United States, 1993 to 2003.
@nl
P2093
P1476
Isoniazid-monoresistant tuberculosis in the United States, 1993 to 2003.
@en
P2093
Andrea J Hoopes
J Steve Kammerer
Kashef Ijaz
Lori R Armstrong
Theresa A Harrington
P304
P356
10.1001/ARCHINTE.168.18.1984
P407
P577
2008-10-01T00:00:00Z